HSCT has been shown to be ineffective for epithelial barrier dysfunctions, such as TTC7A deficiency and nuclear factor-kappa B essential modulator (NEMO) deficiency (11, 12). This evidence concerns the gene IKBKG and hyperinsulinemic hypoglycemia, familial, 4.